Nucleic acid labeling compounds containing heterocyclic derivatives are disclosed. The heterocyclic derivative containing compounds are synthesized by condensing a heterocyclic derivative with a cyclic group (e.g. a ribofuranose derivative). The labeling compounds are suitable for enzymatic attachme
Nucleic acid labeling compounds containing heterocyclic derivatives are disclosed. The heterocyclic derivative containing compounds are synthesized by condensing a heterocyclic derivative with a cyclic group (e.g. a ribofuranose derivative). The labeling compounds are suitable for enzymatic attachment to a nucleic acid, either terminally or internally, to provide a mechanism of nucleic acid detection.
대표청구항▼
The invention claimed is: 1. A nucleic acid labeling compound comprising the formula: wherein A is H or a functional group that permits the attachment of the nucleic acid labeling compound to a nucleic acid; X is O, S, NR1, or CHR2, wherein R1 and R2 are, independently, H, alkyl or aryl; Y is H,
The invention claimed is: 1. A nucleic acid labeling compound comprising the formula: wherein A is H or a functional group that permits the attachment of the nucleic acid labeling compound to a nucleic acid; X is O, S, NR1, or CHR2, wherein R1 and R2 are, independently, H, alkyl or aryl; Y is H, N3, F, OR9, SR9 or NHR9, wherein R9 is H, alkyl or aryl; Z is H, N3, F or OR10, wherein R10 is H, alkyl or aryl; L is amino alkyl; Q is a detectable moiety; and M is a connecting group, wherein m is an integer ranging from 0 to about 3. 2. A nucleic acid labeling compound according to claim 1, wherein A is H or H4O9P3--; X is O; Y is H or OR9, wherein R9 is H, alkyl or aryl; Z is H, N3, F or OR10, wherein R10 is H, alkyl or aryl; L is--NH(CH2)nNH--, wherein n is an integer ranging from about 2 to about 10; Q is biotin or carboxyfluorescein; and M is--CO(CH2)5NH--or--CO(CH2)5NHCO(CH2)5NH--, wherein m is 1 or 0. 3. A nucleic acid labeling compound according to claim 2, wherein Y is H or OH; Z is H or OH; L is--NH(CH2)4NH--; Q is biotin; and M is--CO(CH2)5NH--, wherein m is 1. 4. A nucleic acid labeling compound according to claim 2, wherein Y is H or OH; Z is H or OH; L is--NH(CH2)4NH--; Q is 5-carboxyfluorescein; and M is--CO(CH2)5NH--, wherein m is 1. 5. A nucleic acid labeling compound according to claim 2, wherein A is H; Y is OH; Z is OH; L is--NH(CH2)4NH--; Q is biotin; and M is--CO(CH2)5NH, wherein m is 1. 6. A nucleic acid labeling compound according to claim 2, wherein A is H4O9P3--; Y is OH; Z is OH; L is--NH(CH2)4NH--; Q is biotin; and M is--CO(CH2)5NH, wherein m is 1. 7. A nucleic acid labeling compound according to claim 2, wherein A is H; Y is OH; Z is OH; L is--NH(CH2)4NH--; Q is 5-carboxyfluorescein; and M is--CO(CH2)5NH, wherein m is 1. 8. A nucleic acid labeling compound according to claim 2, wherein A is H4O9P3--; Y is OH; Z is OH; L is--NH(CH2)4NH--; Q is 5-carboxyfluorescein; and M is--CO(CH2)5NH, wherein m is 1. 9. A nucleic acid labeling compound comprising the formula: wherein A is H or a functional group that permits the attachment of the nucleic acid labeling compound to a nucleic acid; X is O, S, NR1 or CHR2, wherein R1 and R2 are, independently, H, alkyl or aryl; Y is H, N3, F, OR9, SR9 or NHR9, wherein R9, is H, alkyl or aryl; Z is H, N3, F or OR10, wherein R10 is H, alkyl or aryl; L is functionalized alkyl, alkenyl alkyl or alkynyl alkyl; Q is a detectable moiety; and M is a connecting group, wherein m is an integer ranging from 0 to about 3. 10. A nucleic acid labeling compound according to claim 9, wherein A is H or H4O9P3--; X is O; Y is H or OR9, wherein R9, is H, alkyl or aryl; Z is H, N3, F or OR10, wherein R10 is H, alkyl or aryl; L is--CH═CH(CH2)nNH--, wherein n is an integer ranging, from about 1 to about 10; Q is biotin or carboxyfluorescein; and M is--CO(CH2)5NH--or--CO(CH2)5NHCO(CH2)5NH--, wherein m is 1 or 0. 11. A nucleic acid labeling compound according to claim 10, wherein Y is H or OH; Z is H or OH; L is--CH═CHCH2NH--; Q is biotin; and m is 0. 12. A nucleic acid labeling compound according to claim 10, wherein Y is H or OH; Z is H or OH; L is--CH═CHCH2NH--; Q is 5-carboxyfluorescein; and m is 0. 13. A nucleic acid labeling compound comprising the formula: wherein A is H or a functional group that permits the attachment of the nucleic acid labeling compound to a nucleic acid; X is O, S, NR1, or CHR2, wherein R1 and R2 are, independently, H, alkyl or aryl; Y is H, N3, F, OR9, SR9 or NHR9, wherein R9 is H, alkyl or aryl; Z is H, N3, F or OR10, wherein R10 is H, alkyl or aryl; L is functionalized alkyl, alkenyl alkyl or alkynyl alkyl; Q is a detectable moiety; and M is a connecting group, wherein m is an integer ranging from 0 to about 3. 14. A nucleic acid labeling compound according to claim 13, wherein A is H or H4O9P3--; X is O; Y is H or OR9, wherein R9 is H, alkyl or aryl; Z is H, N3, F or OR10, wherein R10 is H, alkyl or aryl; L is--CH═CH(CH2)nNH--, wherein n is an integer ranging from about 1 to about 10; Q is biotin or carboxyfluorescein; and M is--CO(CH2)5NH--or--CO(CH2)5NHCO(CH2)5NH--, wherein m is 1 or 0. 15. A nucleic acid labeling compound according to claim 14, wherein Y is H or OH; Z is H or OH; L is--CH═CHCH2NH--; Q is biotin; and m is 0. 16. A nucleic acid labeling compound according to claim 14, wherein Y is H or OH; Z is H or OH; L is--CH═CHCH2NH--; Q is 5-carboxyfluorescein; and m is 0. 17. A nucleic acid labeling compound according to claim 1, wherein the compound has the formula: wherein A is H or a functional group that permits the attachment of the nucleic acid labeling compound to a nucleic acid; X is O, S, NR1, or CHR2, wherein R1 and R2 are, independently, H, alkyl or aryl; Y is H, N3, F, OR9, SR9 or NHR9, wherein R9 is H, alkyl or aryl; Z is H, N3, F or OR10, wherein R10 is H, alkyl or aryl; L is amino alkyl; Q is a detectable moiety; and M is a connecting group, wherein m is an integer ranging from 0 to about 3. 18. A nucleic acid labeling compound according to claim 9, wherein the compound has the formula: wherein A is H or a functional group that permits the attachment of the nucleic acid labeling compound to a nucleic acid; X is O, S, NR1 or CHR2, wherein R1 and R2 are, independently, H, alkyl or aryl; Y is H, N3, F, OR9, SR9 or NHR9, wherein R9 is H, alkyl or aryl; Z is H, N3, F or OR10, wherein R10 is H, alkyl or aryl; L is functionalized alkyl, alkenyl alkyl or alkynyl alkyl; Q is a detectable moiety; and M is a connecting group, wherein m is an integer ranging from 0 to about 3. 19. A nucleic acid labeling compound according to claim 13, wherein the compound has the formula: wherein A is H or a functional group that permits the attachment of the nucleic acid labeling compound to a nucleic acid; X is O, S, NR1 or CHR2, wherein R1 and R2 are, independently, H, alkyl or aryl; Y is H, N3, F, OR9, SR9, or NHR9, wherein R9 is H, alkyl or aryl; Z is H, N3, F or OR10, wherein R10 is H, alkyl or aryl; L is functionalized alkyl, alkenyl alkyl or alkynyl alkyl; Q is a detectable moiety; and M is a connecting group, wherein m is an integer ranging from 0 to about 3. 20. A nucleic acid labeling compound according to claim 1, wherein the compound has the formula: wherein A is H or a functional group that permits the attachment of the nucleic acid labeling compound to a nucleic acid; X is O, S, NR1 or CHR2, wherein R1 and R2 are, independently, H, alkyl or aryl; Y is H, N3, F, OR9, SR9 or NHR9, wherein R9 is H, alkyl or aryl; Z is H, N3, F or OR10, wherein R10 is H, alkyl or aryl; L is amino alkyl; Q is a detectable moiety; and M is a connecting group, wherein m is an integer ranging from 0 to about 3. 21. A nucleic acid labeling compound according to claim 9, wherein the compound has the formula: wherein A is H or a functional group that permits the attachment of the nucleic acid labeling compound to a nucleic acid; X is O, S, NR1 or CHR2, wherein R1 and R2 are, independently, H, alkyl or aryl; Y is H, N3, F, OR9, SR9 or NHR9, wherein R9 is H, alkyl or aryl; Z is H, N3, F or OR10, wherein R10 is H, alkyl or aryl; L is functionalized alkyl, alkenyl alkyl or alkynyl alkyl; Q is a detectable moiety; and M is a connecting group, wherein m is an integer ranging from 0 to about 3. 22. A nucleic acid labeling compound according to claim 13, wherein the compound has the formula: wherein A is H or a functional group that permits the attachment of the nucleic acid labeling compound to a nucleic acid; X is O, S, NR1 or CHR2, wherein R1 and R2 are, independently, H, alkyl or aryl; Y is H, N3, F, OR9, SR9 or NHR9, wherein R9 is H, alkyl or aryl; Z is H, N3, F or OR10, wherein R10 is H, alkyl or aryl; L is functionalized alkyl, alkenyl alkyl or alkynyl alkyl; Q is a detectable moiety; and M is a connecting group, wherein m is an integer ranging from 0 to about 3. 23. A nucleic acid labeling compound according to claim 1, wherein the compound has the formula: wherein A is H or a functional group that permits the attachment of the nucleic acid labeling compound to a nucleic acid; X is O, S, NR1, or CHR2, wherein R1 and R2 are, independently, H, alkyl or aryl; Y is H, N3, F, OR9, SR9 or NHR9, wherein R9 is H, alkyl or aryl; Z is H, N3, F or OR10, wherein R10 is H, alkyl or aryl; L is amino alkyl; Q is a detectable moiety; and M is a connecting group, wherein m is an integer ranging from 0 to about 3. 24. A nucleic acid labeling compound according to claim 9, wherein the compound has the formula: wherein A is H or a functional group that permits the attachment of the nucleic acid labeling compound to a nucleic acid; X is O, S, NR1 or CHR2, wherein R1 and R2 are, independently, H, alkyl or aryl; Y is H, N3, F, OR9, SR9 or NHR9, wherein R9 is H, alkyl or aryl; Z is H, N3, F or OR10, wherein R10 is H, alkyl or aryl; L is functionalized alkyl, alkenyl alkyl or alkynyl alkyl; Q is a detectable moiety; and M is a connecting group, wherein m is an integer ranging from 0 to about 3. 25. A nucleic acid labeling compound according to claim 13, wherein the compound has the formula: wherein A is H or a functional group that permits the attachment of the nucleic acid labeling compound to a nucleic acid; X is O, S, NR1 or CHR2, wherein R1 and R2 are, independently, H, alkyl or aryl; Y is H, N3, F, OR9, SR9, or NHR9, wherein R9 is H, alkyl or aryl; Z is H, N3, F or OR10, wherein R10 is H, alkyl or aryl; L is functionalized alkyl, alkenyl alkyl or alkynyl alkyl; Q is a detectable moiety; and M is a connecting group, wherein m is an integer ranging from 0 to about 3.
Lopez Carlos (New York NY) Watanabe Kyoichi A. (Portchester NY) Reichman Uri (White Plains NY) Fox Jack J. (White Plains NY), Anti-herpes virus compositions containing 5-substituted 1-2′(deoxy-2-′-substituted-b
상세보기
Fodor Stephen P. A. (Palo Alto CA) Pirrung Michael C. (Durham NC) Read J. Leighton (Palo Alto CA) Stryer Lubert (Stanford CA), Array of oligonucleotides on a solid substrate.
Muhlegger Klaus,DEX ; Von der Eltz Herbert,DEX ; Seela Frank,DEX ; Rosemeyer Helmet,DEX, C-nucleoside derivatives and their use in the detection of nucleic acids.
Hubbell Earl A. (Mt. View CA) Morris MacDonald S. (San Jose CA) Winkler James L. (Palo Alto CA), Computer-aided engineering system for design of sequence arrays and lithographic masks.
Seela Frank,DEX ; Muth Heinz-Peter,DEX ; Kaiser Klaus,DEX ; Bourgeois Werner,DEX ; Muhlegger Klaus,DEX ; Von der Eltz Herbert,DEX ; Batz Hans-Georg,DEX, Desazapurine-nucleotide derivatives, processes for the preparation thereof, pharmaceutical compositions containing them and the use thereof for nucleic acid sequencing and as antiviral agents.
Pirrung Michael C. (Durham NC) Read J. Leighton (Palo Alto CA) Fodor Stephen P. A. (Palo Alto CA) Stryer Lubert (Stanford CA), Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof.
Drmanac Radoje T. (Zvecanska 46 Beograd 11000) Crkvenjakov Radomir B. (Bulevar JNA 118 Beograd YUX 11000), Method of sequencing of genomes by hybridization of oligonucleotide probes.
Prober James M. (Wilmington DE) Dam Rudy J. (Landenberg PA) Robertson ; Jr Charles W. (Rockland DE) Hobbs ; Jr. Frank W. (Wilmington DE) Trainor George L. (Glen Mills PA), Method, system and reagents for DNA sequencing.
Prober James M. (Wilmington DE) Dam Rudy J. (Landenberg PA) Robertson ; Jr. Charles W. (Rockland DE) Hobbs ; Jr. Frank W. (Wilmington DE) Trainor George L. (Glen Mills PA), Method, system and reagents for DNA sequencing.
Ward David C. (Guilford CT) Langer Pennina R. (Monsey NY) Waldrop ; III Alexander A. (Charlottesville VA), Modified nucleotides and methods of preparing and using same.
Mishra Nrusingha C. (Germantown MD) Khorshidi Hossein S. (Vienna VA) Gan Yuxiang (Bethesda MD) Szweda Pam (Cleveland Heights OH) George Jay (Gaithersburg MD), Modified nucleotides for nucleic acid labeling.
Fodor Stephen P. A. (Palo Alto CA) Stryer Lubert (Stanford CA) Pirrung Michael C. (Durham NC) Read J. Leighton (Palo Alto CA), Very large scale immobilized polymer synthesis.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.